Glyscend Incorporated
0 followers
‌
Founded in 2014, Glyscend is dedicated to the development of a truly revolutionary approach to treating type 2 diabetes.
Industries
Headquarters
Employees
Links
Org chart
Sapan Shah
CEO
Sapan Shah
Collapse
Thomas Jozefiak
Chief Scientific Officer
Ashish Nimgaonkar
Chief Medical Officer & Head, R&D
Mark Fineman
Chief Development Officer
John Petersen
VP, CMC
Kevin Colbert
Senior Director, Operations & Strategy
Bob Soh
Director
